Primary Care Physician Experiences with Integrated Pharmacogenomic Testing in a Community Health System
Open Access
- 2 August 2017
- journal article
- Published by Taylor & Francis in Personalized Medicine
- Vol. 14 (5) , 389-400
Abstract
Aim: To explore primary care physicians’ views of the utility and delivery of direct access to pharmacogenomics (PGx) testing in a community health system. Methods: This descriptive study assessed the perspectives of 15 healthcare providers utilizing qualitative individual interviews. Results: Three main themes emerged: perceived value and utility of PGx testing; challenges to implementation in practice; and provider as well as patient needs. Conclusion: While providers in this study viewed benefits of PGx testing as avoiding side effects, titrating doses more quickly, improving shared decision-making and providing psychological reassurance, challenges will need to be addressed such as privacy concerns, cost, insurance coverage and understanding the complexity of PGx test results.Keywords
Funding Information
- “Principles and clinical applications of next-generation DNA sequencing”
This publication has 40 references indexed in Scilit:
- Personalized medicine: Genetic risk prediction of drug responsePharmacology & Therapeutics, 2017
- Integrating Pharmacogenomics into Clinical Practice: Promise vs RealityThe American Journal of Medicine, 2016
- Consumer Perceptions of Interactions With Primary Care Providers After Direct-to-Consumer Personal Genomic TestingAnnals of Internal Medicine, 2016
- Clinician Perspectives on Using Pharmacogenomics in Clinical PracticePersonalized Medicine, 2015
- Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development ProcessCurrent Drug Metabolism, 2014
- Physicians' Preparedness for Integration of Genomic and Pharmacogenetic Testing into Practice Within a Major Healthcare SystemGenetic Testing and Molecular Biomarkers, 2013
- Primary care physicians' knowledge of and experience with pharmacogenetic testingClinical Genetics, 2012
- Adoption of Pharmacogenomic Testing by US Physicians: Results of a Nationwide SurveyClinical Pharmacology & Therapeutics, 2012
- Professional Perspectives About Pharmacogenetic Testing and Managing Ancillary FindingsGenetic Testing and Molecular Biomarkers, 2012
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research NetworkClinical Pharmacology & Therapeutics, 2011